Here is a formal academic-style abstract:

"This 2024 cohort study evaluates the diagnostic accuracy of a novel plasma phosphorylated tau 217 immunoassay for Alzheimer disease pathology. Results demonstrate the assay's potential to identify Alzheimer disease pathology with high precision, thereby enhancing diagnostic capabilities and informing clinical decision-making."